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Abstract. The human connectome at the level of fiber tracts between brain regions has been 
shown to differ in patients with brain disorders compared to healthy control groups. 
Nonetheless, there is a potentially large number of different network organizations for 
individual patients that could lead to cognitive deficits prohibiting correct diagnosis. 
Therefore changes that can distinguish groups might not be sufficient to diagnose the disease 
that an individual patient suffers from and to indicate the best treatment option for that 
patient. We describe the challenges introduced by the large variability of connectomes within 
healthy subjects and patients and outline three common strategies to use connectomes as 
biomarkers of brain diseases. Finally, we propose a fourth option in using models of 
simulated brain activity (the dynamic connectome) based on structural connectivity rather 
than the structure (connectome) itself as a biomarker of disease. Dynamic connectomes, in 
addition to currently used structural, functional, or effective connectivity, could be an 
important future biomarker for clinical applications.  
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The study of how different components of the brain, may they be neurons or brain regions, 
are connected has become an emerging field within the neurosciences (Bullmore and Sporns, 
2009; Kaiser, 2011; Sporns et al., 2004). The analysis of physical connections within neural 
systems gained momentum around 20 years ago with the availability of information on the 
nematode Caenorhabditis elegans’ nervous system (Achacoso and Yamamoto, 1992; White 
et al., 1986) and the rhesus monkey’s visual system of cortico-cortical connections (Felleman 
and van Essen, 1991; Young, 1992). Now called connectomics, the field aims to discover the 
structure of brain networks, representing physical connections such as axons or fiber tracts. 
As a next milestone, the first data sets of the Human Connectome Project are being released. 
What will the next 20 years bring?  Like for genomics, the hopes are that features of the 
connectome of a patient can be a biomarker for diseases and an indicator for therapeutic 
interventions. Identifying biomarkers for diseases based on large-scale genome studies has 
been challenging. Is the link between connectivity and brain disease also over-weighted? 
What could a structural connectome in principle tell us about the brain organization in health 
and disease? 
 
 
In analogy to genetics, we may distinguish a genotype and a phenotype of brain organization. 
The genotype is given by the structural connectivity either observed at the level of individual 
synapses (microconnectome) or at the level of fiber tracts between brain regions 
(macroconnectome) (DeFelipe, 2010) and we will refer to this as connectome. As for every 
novel field, the underlying techniques are still under development (Jbabdi and Johansen-
Berg, 2011). Diffusion tensor and diffusion spectrum imaging can give us information on 
potential structural connections of the macroconnectome. The phenotype represents activity, 
as seen in fMRI or EEG, or behavior, as for cognitive clinical scores. We refer to these 
patterns as consequences on dynamics or behavior due to changed brain connectivity. 
 
The problem of diagnosing a disease, as in genetics, is due to the fact that several mutations 
of the genotype might result in the same phenotype (disease). Observing brain connectivity, 
there might be several combinations of changes in fiber tracts leading to hallucinations or 
seizures, for example. Also, the same connectome organization might lead to different 
dynamics for changes that affect the internal anatomy and activity of network nodes but not 
the nodes’ topology (Figure 1). The idea that many pathways can lead to similar behavior is 
linked to the concept of degeneracy (Price and Friston, 2002; Tononi et al., 1999), ‘the ability 
of elements that are structurally different to perform the same function or yield the same 
output.’ If the output (phenotype) is cognitive deficits in patients, the number of connectome 
(genotype) patterns that lead to such behavior can be seen as the degeneracy of a brain 
disease. Also, a higher degeneracy, meaning that more connectome patterns are linked to a 
disease, might result in a higher incidence in a population. A related observation has been 
made in the field of genetics when linking genetic changes to diseases: multiple genotypes 
might lead to the same phenotype (heterogeneity) (Addington and Rapoport, 2012). 
Therefore, detecting one connectivity pattern linked to a disease might only relate to a 
fraction of all patients. Moreover, many connectome changes will be neutral in that they do 
not lead to a brain disorder; thus variability in the healthy population is expected to be large 
as well. As for genetics, connectomics is currently moving to large-scale studies, e.g. the 
1,200-subject Human Connectome Project or the 1,000-subject Functional Connectomes 
study, to address this underlying variability.  
 
Another problem besides large connectome variability (‘noise’) is that cognitive deficits 
might arise from small changes (‘signal’). Development can be seen as a system of nonlinear 
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dynamics (Turing, 1952). It has become clear that genetic encoding (Kendler et al., 2011) and 
self-organization shape the formation of neural systems in health and disease. For self-
organization, the interaction with the environment (external factors) or physical constraints 
(internal factors) can influence the establishment and survival of axonal connections.  
Consequently, small changes during development might lead to a different connectome and 
as a result to a different resulting consequence for cognition and behavior of human subjects. 
As the dynamics in the brain are also non-linear, a small change in structural connectivity 
might be sufficient to lead to changes in cognition and behavior. Relatively small changes in 
connectivity might be sufficient to lead to a brain disorder. Therefore, some connectivity 
patterns seen in patients might be quite close to the organization of healthy subjects.  
 
Let us look at some cases of how brain diseases could be linked to brain connectivity. Also, 
let us only use two cases of how a network structure (edge or node) in a patient could differ 
from that of a control group: a significant increase or a significant decrease of a network 
measure. We will only look at a single measure here, say number of streamlines for edges 
and total strength of its connections for nodes, but our general observations also hold for a 
combination of network measures (Costa et al., 2007; Kaiser et al., 2009; van den Heuvel et 
al., 2012).   
 
First, a disease might affect a single brain region which could have an effect on brain 
dynamics by changing its own activity pattern, the pattern of directly connected neighbors of 
the region, and, indirectly, the activity in the rest of the brain mediated by intermediate brain 
regions. As a simplification, let us assume that only structural connections from that brain 
region will be altered. As each brain region (for a parcellation in humans of 110 cortical and 
subcortical regions including both hemispheres) is connected to around 10 other brain 
regions, there are 210 = 1,024 possible changes assuming that each connection could either be 
significantly increased or decreased in a patient. Thus even at the local scale, only affecting a 
single brain region, many variations of a disease are possible.   
 
Second, a disease could affect a set of network nodes. For example, regions of the neocortex 
mature at different times during development: medial regions before lateral regions and 
posterior before anterior regions. A change in the maturation of the frontal lobe could affect 
multiple regions at the same time and might affect a whole network module (Nisbach and 
Kaiser, 2007). Say that 10 regions show a different internal structure that also manifests itself 
in altered fiber tracts between them and other brain regions. Therefore, assuming 10 fiber 
tracts per brain region, or 102 = 100 fiber tracts for all 10 affected regions, show changes 
leads to 2100 = 1.3 * 1030 variants. Let us look at a simpler model where an increase (or a 
reduction) in at least 10 of those 100 fiber tracts is sufficient to lead to the behavioral features 
of a disease. There are 
100
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!
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#
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%
&  = 1.7 * 1013 ways to choose 10 out of 100 connections. Given 
that 10 is the lower bound for disease onset, choosing 11, 12, 13, etc. connections leads to 
even more variations at this regional level. 
 
Third, a disorder could lead to changes of a set of edges at the global level as a result of 
widely distributed changes. If there are 500 bidirectional connections (fiber tracts) between 
our 110 brain regions, there are 2500 = 3.3 * 10150 possible changes compared to a benchmark 
brain based on a population of healthy subjects.  
 
We know that there is huge variability not only in the surface shape of human brains but also 
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in its related connectivity pattern (Hilgetag and Barbas, 2006; Van Essen, 1997). Clearly, 
only a small fraction of connectome patterns is linked to a brain disorder. Even if we assume 
that there are thousands of subtypes of brain disorders, e.g. different kinds of epilepsy, and 
that many diseases change synaptic efficacy without changing structural connectivity, there 
might still be billions of connectome changes that could lead to the clinical patterns observed 
in patients with one type of a disease. Clearly, no two patients are the same (neither are no 
two control subjects). 
 
If there is a multitude of ways how connectome changes could lead to a disease, how can we 
use brain connectivity information to inform the diagnosis and treatment of clinical patients? 
First, some links between connectome and consequential brain dynamics might manifest 
themselves through changes of global network features despite the variability in the changes 
of individual connections. Examples are global topological changes, observed through 
diffusion tensor imaging, in remitted geriatric depression and amnestic mild cognitive 
impairment (Bai et al., 2012). However, the same global changes, say a deviation from the 
brain’s small-world organization towards random or regular connectivity (Reijneveld et al., 
2007), could be observed across diseases and therefore limit their use as a classifier for brain 
diseases.  
 
Second, some changes might be so widespread that they affect the majority or all of the brain 
regions leaving fewer degrees of freedom for variability in connectomes. The overall pattern 
of altered structural connectivity in schizophrenia patients (Skudlarski et al., 2010), along 
with resulting functional connectivity changes (Fornito et al., 2012), would be one example 
for this case.  
 
Third, changes that are linked to a brain disease might only affect specific circuits in the 
network. In that way, while the strength of most connections also varies in healthy controls, 
more consistent changes to specific fiber tracts would be expected for patients. As a 
consequence, changes in selected circuits would be common for a group of patients but a 
consistent change for all fiber tracts of a circuit would not occur in control subjects. While 
this is a potentially powerful approach it does need a priori knowledge about the affected 
circuit. Such circuits might be identified by large-cohort studies in patients or through 
‘knock-out’ studies, e.g. using transcranial magnetic stimulation (Hilgetag et al., 2001), in 
healthy subjects.  
 
 
Finally, I would propose a novel approach to deal with the variability in brain disorders, 
which is the use of computer simulations of brain activity, based on the connectivity in 
individual patients. Such simulations are already emerging as a way to understand the 
structural correlates of dynamical changes and disease progression (Cabral et al., 2012; Deco 
et al., 2011; Raj et al., 2012). As shown above, multiple structural connectivity changes 
might lead to the same changes in brain dynamics, patient behavior, or clinical test scores. 
Simulating the activity in the brain of individual patients can inform us about the expected 
behavioral features and thus about the presence or absence of one sub-type of brain disorder. 
These models can go beyond the observation of patterns in the recordings of brain activity as 
simulated dynamics could include more complex models. For example, a model based on 
structural connectivity might include simulated activity of individual neurons or local 
circuits, which cannot be observed by non-invasive neuroimaging. 
 
Using simulations in a clinical setting has several benefits. First, simulated behavioral 
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features can be mapped to brain activity in patients that is available through fMRI, PET, 
MEG, EEG, ECoG, or recordings in resected tissue (Roopun et al., 2010), depending on the 
disease. Second, the simulated behavior can be compared with the experimentally obtained 
behavior to validate and constrain a model: simulated activity can be compared with the 
clinical recordings of a patient. Third, observing dynamics in networks opens up the 
possibility to use the tools of nonlinear dynamics and time series analysis to find patterns that 
could be biomarkers for a given disease. Importantly, changes in brain dynamics might be 
visible even in cases where the structural connectivity is not significantly different from that 
of a healthy control group. Such simulations are becoming available both at the local (Blue 
Brain Project, (Markram, 2006)) and global level (Virtual Brain Project, (Jirsa et al., 2010)) 
and will be support through the Human Brain Project and other initiatives. 
 
In conclusion, there is a large number of underlying structural connectome changes that 
might lead to the same functional and behavioral changes in healthy subjects and patients. 
This variety makes the detection of a brain disorder—not just the classification of the type of 
disorder (Hyman, 2010)—difficult. We propose the use of computer models to use the 
simulated dynamics (dynamic connectome) based on structural connectivity, rather than the 
directly measured structural connectivity alone, as a biomarker. In the same way that biology 
has moved from genes to gene expression data, the use of dynamic connectomes, observing 
or simulating activity in neural circuits, opens up future potential for clinical applications. 
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Figure 1. Mapping between underlying developmental causes of connectome changes, 
ranging from genetic factors to spatiotemporal epigenetic factors, to resulting brain 
connectivity (‘connectome’), observable network behavior (‘consequence’), and final disease 
classification. Similar patterns within each of the four categories are shown in red. Note that 
both genetic patterns and network features alone may be insufficient to inform the clinical 
diagnosis of a disease: First, the same genetic mutation A might lead to a different 
connectivity due to different epigenetic factors. Second, different genetic mutations A & B 
could lead to the same connectivity due to additional factors. Third, the same connectivity 
might lead to different behavior and disease classification due to changes that solely affect 
the anatomical organization within individual nodes.   
  
 
